STAT activation inhibitory protein 2 is involved in reprogramming of lipid metabolism by regulating the prostate cancer development
10.3969/j.issn.1006-5725.2025.18.009
- VernacularTitle:STAT活化抑制蛋白2基因在前列腺癌中的表达水平及与临床病理特征的关系
- Author:
Weizun LI
1
;
Chen XING
1
;
Hengqing AN
1
Author Information
1. 新疆医科大学第一附属医院泌尿外科(新疆 乌鲁木齐 830000)
- Publication Type:Journal Article
- Keywords:
prostate cancer;
STAT activation inhibitory protein 2;
immunohistochemistry;
lipid me-tabolism reprogramming
- From:
The Journal of Practical Medicine
2025;41(18):2844-2852
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression level of the protein inhibitor of the activated STAT2(PIAS2)gene in prostate cancer and its relationship with clinicopathological features,and the potential role of PIAS2 in reprogramming lipid metabolism in prostate cancer.Methods The Cancer Genome Atlas Program(TCGA)database and HPA immunohistochemical analysis were used to show the expression of PIAS2 protein;qRT-PCR,Western bolt and immunohistochemistry were used to detect PIAS2 in prostate cancer tissues and their paracancerous tissues.PIAS2 expression in prostate cancer tissues and its paracancerous tissues and analyzed its relationship with clinicopathological features of patients;lentivirus infected prostate cancer cell line PC-3M,which stably knocked down PIAS2,was analyzed by ultra performance liquid chromatography mass spectrometry(UPLC-MS)for lipidomics.Results TCGA analysis showed that the expression of PIAS2 in prostate cancer tissues was higher than that in paracancerous tissues,and HPA immunohistochemistry analysis showed that PIAS2 protein was highly expressed in prostate cancer tissues;the expression of PIAS2 mRNA and protein was significantly elevated in prostate cancer compared with that in paracancerous tissues,and the difference was statistically significant(P<0.05);immunohistochemistry showed that PIAS2 protein Expression of PIAS2 protein was mainly localized in the nucleus of prostate,and the AOD value of prostate cancer tissues was significantly higher than that of paraneoplastic tissues:the results of clinicopathological parameters showed that PIAS2 had correlation with Gleason score and TNM stage(P<0.05),while there was no statistically significant correlation with the age of the patients,PSA and lymph node metastasis;UPLC-MS analysis suggested that the knockdown of PIAS2 affected 10 lipid changes,with down-regulation of phosphatidylcholine and phosphatidylethanolamine and up-regulation of phosphatidylinosi-tol,phosphatidylserine,diacylglycerol,and triacylglycerol in the shPIAS2 group compared with the shNC group.Conclusions The expression of PIAS2 protein was significantly elevated in prostate cancer tissues,suggesting that PIAS2 is associated with the development of prostate cancer,and its pathogenesis may be related to the abnormal lipid metabolism of prostate cancer.
